个人简介
Pharmacy, Bachelors, DR. MGR Medical University, India - 1998
MSc Pharmacology and Biotechnology, Sheffield Hallam University, UK - 2000
PhD Molecular and Cellular Neuroscience, University of Bristol, UK - 2004
APD in Management Studies (level7), City of Bristol College, UK - 2006
PGCHEP (postgraduate certificate in higher education practice) (Sep 2013 – July 2015)
University of Bradford, Bradford, UK
2011- June 2013: Research Fellow, Dept of Genetics, Research centre, King Faisal Specialist Hospital, Riyadh, Saudi Arabia
2005 - 2010: Research Associate, MRC Centre for Synaptic Plasticity, University of Bristol, Bristol, UK
研究领域
Neuronal membrane proteins, receptor trafficking and degradation, protein-protein interactions, Glutamate / GABA receptors and post-translational modification
近期论文
查看导师最新文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
Sriharsha Kantamneni (2015) Cross-talk and regulation between glutamate and GABAB receptors. Front Cell Neurosci. 9:135. doi: 10.3389/fncel.2015.00135
Sriharsha Kantamneni*, Immaculada M. Gonzàlez-Gonzàlez, Helena I Cimarosti, Jia Luo, Nadia Jaafari and Jeremy M Henley* (2014). Differential regulation of GABAB receptor trafficking by different modes of NMDA receptor signaling. J Biol Chem. 289(10): 6681–6694. (*co-corresponding author)
Nadia Jaafari, Filip Konopacki, Thomas F. Owen, Sriharsha Kantamneni, Philip Rubin, Tim J. Craig, Kevin A. Wilkinson and Jeremy M. Henley (2013). USUMOylation is required for glycine-induced increases in AMPA receptor surface expression (ChemLTP) in hippocampal neuronsU. PLoS ONE. 8(1):e52345
Sophie E L Chamberlain, Inmaculada M González-González, Kevin A Wilkinson, Filip A Konopacki, Sriharsha Kantamneni, Jeremy M Henley & Jack R Mellor (2012). SUMOylation and phosphorylation of GluK2 regulate kainate receptor trafficking and synaptic plasticity Nature Neuroscience. 15(6):845-52
Sriharsha Kantamneni, Kevin A. Wilkinson, Nadia Jaafari, Emi Ashikaga, Daniel Rocca, Philip P. Rubin, Susan C. Jacobs, Atsushi Nishimune and Jeremy M. Henley. (2011) Activity-dependent SUMOylation of the brain-specific scaffolding protein GISP. Biochem Biophys Res Commun. 409(4):657-62
Filip Konopacki, Nadia Jaafari, Dan L. Rocca, Kevin A. Wilkinson, Sophie Chamberlain, Philip Rubin, Sriharsha Kantamneni, Jack R. Mellor and Jeremy M. Henley (2011). Agonist-induced PKC phosphorylation regulates GluK2 SUMOylation and kainate receptor endocytosis. Proc Natl Acad Sci USA. 108(49):19772-7
Laura Ceolin, Sriharsha Kantamneni, Gareth R. Barker, Lydia Hanna, Lynnette Murray, Elizabeth C. Warburton, Emma S. Robinson, James A. Monn, Stephen M. Fitzjohn, Graham L. Collingridge, Zuner A. Bortolotto and David Lodge. (2011) Study of Novel Selective mGlu2 Agonist in the Temporo-Ammonic Input to CA1 Neurons Reveals Reduced mGlu2 Receptor Expression in a Wistar Substrain with an Anxiety-Like Phenotype. J Neuroscience. 31(18):6721-31
Sriharsha Kantamneni, Kevin A. Wilkinson and Jeremy M. Henley. (2011) Ubiquitin regulation of neuronal excitability. Nature Neuroscience. 14(2):126-8
Sriharsha Kantamneni, David Holman*, Kevin A. Wilkinson*, Atsushi Nishimune and Jeremy M. Henley. (2009) UGISP increases neurotransmitter receptor stability by down-regulating ESCRT-mediated lysosomal degradation. Neuroscience Letters. 452(2): 106-10
Helena Cimarosti*, Sriharsha Kantamneni* and Jeremy M. Henley. (2009) Changes in GABAB receptors following ischemic challenges in organotypic cultures. Neuropharmacology. 56(8): 1088-96. (*Equal contribution)
Sriharsha Kantamneni*, David Holman*, Kevin A. Wilkinson, S?nia A.L. Corrêa, Marco Feligioni, Simon Ogden, William Fraser, Atsushi Nishimune and Jeremy M. Henley. (2008) GISP binding to TSG101 increases GABAB2 receptor stability by down-regulating ESCRT-mediated lysosomal degradation. J. Neurochemistry. 107(1): 86-95. (*Equal contribution)
Sriharsha Kantamneni, S?nia A.L. Corrêa, Gina K. Hodgkinson, Guido Meyer, Ngoc Nga Vinh, Jeremy M. Henley and Atsushi Nishimune. (2007). UGISP: A novel brain specific protein that promotes surface expression and function of GABAB receptors. J. Neurochemistry 100(4); 1003-17